Organized by
In collaboration with
Under the auspices of

Coming soon

MELANOMA BRIDGE

December 30th - 2nd, 2023

FACULTY

Sanjiv S. Agarwala

Professor of Hematology & Oncology, Temple University School of Medicine, Philadelphia, PA, US

 Ana Arance

Researcher, Clinic Barcelona, Barcelona, Spain

 Paolo A. Ascierto

Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy

Allison Betof Warner

Assistant Professor of Medicine (Oncology), Director, Melanoma Medical Oncology Program, Director, Solid Tumor Cellular Therapy Leader, Melanoma & Cutaneous Oncology Clinical Research Group, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA, US

 Christian Blank

Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam; Medical Oncology, Leiden University Medical Center (LUMC), Leiden, Netherlands

Corrado Caracò

Director of Melanoma and Skin Tumor Surgery, National Cancer Institute, IRCCS “Fondazione G. Pascale”, Naples, Italy

Richard D. Carvajal

Director of Experimental Therapeutics, Director of the Melanoma Service, Columbia University Medical Center, New York, NY, US

Michele Del Vecchio

Responsabile S.S. Oncologia Medica Melanomi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Reinhard Dummer

Vice Director, Department of Dermatology; Director, Clinical Trials Comprehensive Cancer Center Zurich (CCCZ), University Hospital Zurich, Zurich, Switzerland

Alexander M.M. Eggermont

Chief Scientific Officer, Board of Directors, Princess Máxima Center; Professor of Clinical & Translational Immunotherapy, Utrecht University, Utrecht, Netherlands

Marc S. Ernstoff

Branch Chief, ImmunoOncology Branch (IOB), Developmental Therapeutics Program, Cancer Therapy & Diagnosis Division, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US

Laura K. Ferris

Director of Clinical Trials, UPMC Department of Dermatology, UPMC Hillman Cancer Center, University of Pittsburgh, PA, US

Jeffrey E. Gershenwald

Dr. John M. Skibber Endowed Professor of Surgery, Department of Surgical Oncology, Medical Director, Melanoma and Skin Center, The University of Texas, MD Anderson Cancer Center, Distinguished Senior Lecturer, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA

 Samantha Guild

President AIM at Melanoma Richmond, CA, US

Omid Hamid

Chief of Research/ Immuno-Oncology, Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, US

Mustafa Khasraw

Professor of Neurosurgery, Professor in Medicine, Member of the Duke Cancer Institute, Durham, NC, USA

 Samir N. Khleif

Director of the Center for Immunology and Immunotherapy, Director of The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical School, Washington, DC, US

Simone Krebs

Assistant Attending Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Michelle Krogsgaard

Associate Professor of Pathology, Co-leader of Tumor Immunology Program, Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, US

Roger S. Lo

Professor of Medicine/Dermatology, Associate Chief of Dermatology, Director of the Dermatology STAR Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, US

Jason J. Luke

Director, Immunotherapy and Drug Development Center, Associate Professor of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, US

Amanda Lund

Associate Professor, Ronald O. Perelman Department of Dermatology, Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY US

Mario Mandalà

Associate Professor of Medical Oncology, University of Perugia, Perugia, Italy

Francesco Marincola

Chief Scientific Officer, Sonata Therapeutics, Watertown, MA, US

Marius E. Mayerhoefer

Member of the Faculty, Department of Radiology, NYU Grossman School of Medicine, New York, NY, US

Janice M. Mehnert

Professor of Medicine, Associate Director for Clinical Research, Laura and Isaac Perlmutter Cancer Center, Director, Melanoma and Cutaneous Medical Oncology, NYU Grossman School of Medicine, New York, NY, US

Olivier Michielin

Full Professor, Chair of Oncology Department and Precision Oncology Service, Geneva University Hospital, Geneva; Co-Director of the Swiss Cancer Center Léman, Agora – Lausanne, Switzerland

Luigi Nezi

Group leader for Microbiome and T Cell Metabolism in Cancer, IEO-  istituto Europeo di Oncologia

Milan, Italy

Iman Osman

Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, NYU Grossman School of Medicine, New York, NY, US

Giuseppe Palmieri

Full Professor of Medical Oncology, University of Sassari; Head of Unit of Cancer Genetics, National Research Council (CNR), Sassari, Italy

Anna Pavlick

Director, WCM Melanoma and Cutaneous Oncology Program, Weill Cornell Medical College, New York, New York, US

Claudia Piazza Cidonio

Co-Founder, Melanoma Italia Onlus, Rome, Italy

 Michael A. Postow

Chief, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, US

Poulikos I. Poulikakos

Professor, Department of Oncological Sciences, Precision Immunology Institute, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York NY, US

Igor Puzanov

Senior Vice President, Clinical Investigation; Professor of Oncology and Medicine, Director of Center for Early Phase Clinical Trials Division, Chief, Melanoma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US

Dirk Schadendorf

Director of the Department of Dermatology, University Hospital Essen, Essen, Germany

Mayra Shanley

Principal Research Scientist, Stem Cell Transplantation Department, MD Anderson Cancer Center, Houston, Texas, US

Alexander Shoushtari

Clinical Director, Melanoma Service; Member, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA

James Smithy

Assistant Attending Physician Melanoma & Cellular Therapy Services

Memorial Sloan Kettering Cancer Center, New York, NY, US

Jeffrey A. Sosman

Professor of Medicine, Director, Melanoma program, Director, Faculty Development, Co-Leader, Translational Research in Solid Tumors, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, US

Ryan J. Sullivan

Associate Professor of Medicine, Harvard Medical School; Associate Professor of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, US

Hussein A. Tawbi

Deputy Chair and Director of Personalized Cancer Therapy, Department of Melanoma Medical Oncology, Division of Cancer Medicine, Co-Director, MD Anderson Brain Metastasis Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Alessandro Testori

Chairman surgical subgroup, EORTC Melanoma Group, Brussels, Belgium

Magdalena Thurin

Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US

Thach-Giao Truong

Melanoma Program Medical Director, Cleveland Clinic,  Cleveland, OH, US

Lisa Villabona

Affiliated to research, Department of Oncology-Pathology, Karolinska Institutet, Cancer Centrum Karolinska (CCK), Karolinska University Hospital, Stockholm, Sweden

Jeffrey S. Weber

Deputy Director, Laura and Isaac Perlmutter Cancer Center, Professor of Oncology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, US